Argus retinal prosthesis, also known as a bionic eye, is an electronic retinal implant manufactured by the American company Second Sight Medical Products. It is used as a visual prosthesis to improve the vision of people with severe cases of retinitis pigmentosa.

2019年12月2日 · These prostheses can help replace the function of the photore­ceptors and stimulate secondary retinal neurons to create a visual image. The Argus II device (Second Sight Medical Products) is the only FDA-approved epiretinal implant at this time.

2015年6月30日 · The Argus II Retinal Prosthesis System is a three-part device that allows some perception of light and motion in patients who have lost their vision due to retinitis pigmentosa. Surgery is done to place a small electronic device on the patient's retina.

argus ii The world’s first FDA-approved¹ device for providing artificial vision. Launched in 2011, The Argus ® Retinal Prosthesis System (“Argus II”) is a retina implant that has successfully helped hundreds of profoundly blind people see light and motion.

The Argus II retinal prosthesis system (Second Sight Medical Products, Sylmar, CA, USA) is an epiretinal device approved for implantation in the USA in patients with end-stage retinitis pigmentosa (RP).

The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products) is the first prosthetic vision device to obtain regulatory approval in both Europe and the USA. As such it has entered the commercial market as a treatment for patients …

2015年6月23日 · The findings show that the Argus II significantly improves visual function and quality of life for people blinded by retinitis pigmentosa. They were published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.

2018年9月4日 · The Argus II retinal prosthesis system surrogates the function of damaged photoreceptors and degenerated outer retinal cells through which the patient may regain functional visual abilities (Ghodasra et al., 2016).

2016年1月1日 · The Argus ® II Retinal Prosthesis System (Second Sight Medical Products) is the first prosthetic vision device to obtain regulatory approval in both Europe and the USA.

The Argus ® II implant, developed by Second Sight Medical Products (SSMP, Sylmar, CA, USA), targets the retina and features 60 electrodes that electrically stimulate the surviving retinal neurons. Of the approximately 20 research groups that are actively developing visual prostheses, SSMP has the longest track record.